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CHAPTER I
INTRODUCTION
Congenital malformations suCh as cleft palate have been produced
in laboratory animals by various modalities.

Cleft palate in humans is

a congenital defect that occurs approximately one in every eight hundred
live births (Grace, 1943).

This defect is the result of the failure of

the palatine processes to meet and fuse during a specific time in embryological development.

In untreated cases severe handicaps appear.

Speech,

mastication,· deglutition and respiration are affected and as a result
psychologic problems develop.

In 1940, Warkany and Nelson showed that

nutritional disturbances were contributing factors to cleft palate production.

Fogh-Andersen (1942) demonstrated that genetic factors were

also important.

Strean and Peer (1956) thought that physiologic, emo-

tional or traumatic stress played a role in human clefts by stimulating
the adrenal cortex to secrete hydrocortisone.

This appeared to correlate

with the animal studies of Baxter and Fraser (1950) , Fraser and Fainstat
(1951), and Kalter (1957) who were able to_ produce clefts in mice before
birth by giving cortisone to pregnant A/Jax mice.

Experimental production

of cleft palate with cortisone in inbred mice has provided a convenient
and a reliable tool for investigation into the mechanism of congenital
malformations.

For over 20 years investigators have reported induction

of cleft palates in the offspring of mice after maternal injection of

~
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~

corticoids.
1
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Baxter et al (1950), and Fraser et al (1951) established that the
offspring of A/Jax mice were 100% susceptible to cleft palate when maternally injected with 2.5 mg. of cortisone acetate on day 11, 12, 13, and
14 of gestation.

Chaudhry and associates (1967) reported that a single

intramuscular injection of 10 mg. of cortisone acetate would induce 100%
cleft palate if injected on the 11, 12, 13 or 14th day of gestation in
the same strain of mouse.

Ingalls and Curley (1957) reported the same

observation when hydrocortisone (cortisol) was injected instead of cortisane.
It has been established that a strain difference appears to exist
between the A/Jax and C57bl in their sensitivity toward cortisone acetate
or hydrocortisone.

Fraser reports this difference to be variable accor-

ding to the genetic constitution of the treated mice, the dosage of cortisone used and the gestational stage at which treatment is begun.

The

C57bl strain has been shown to be constitutionally more resistant to the
cleft palate inducing effects of the cortisone:
ported 17-21% of fetuses had cleft palates.

Walker and Fraser re-

All previous work, which has

been done on the C57bl strain utilized a total teratogenic dose of 10 mg.
administered over a four day period at the rate of 2.5 mg./day.
In as much as most of the cleft palate studies now being done
utilizing the A/Jax strain have adopted the single dose injection technique and in order to facilitate any future comparative study with the
C57bl strain, the purpose of this study is as follows:
1.

To determine if a single dose injection technique is feasible
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for this C57bl strain of mouse.
2.

To compare the multi-injection technique with the single in-

jection technique with particular emphasis on the number of non-viable
fetuses and resorptions as well as the number and percentage of clefts.
3.

To determine if fetal weights of the cleft animals differs

significantly from the weights of the normal fetuses.
4.

To determine if the maternal weights during gestation are

related to the cleft formation.
5.

To determine what percentage of clefts per animal per viable

fetus can be obtained utilizing the single injection technique as opposed to the multi-injection techniques that have been utilized in the
past.
6.

To correlate uterine position with incidence of imperfect

fetuses.
7.

To determine what other teratogenic effects are observed in

the fetuses which could be related to the drug.
8.

Finally, an A/Jax control group is included which will receive

a single injection of the drug on the optimal day for cleft production
as reported by Chaudhry (1967} to determine that cleft palate percentage
in our laboratory is similar to that reported by other investigators.

I

OIAPTER 2

REVIEW OF LITERATURE

A.

Metabolism of the Corticosteroids.
The secretory products of the adrenal cortex are hormones which

resemble the lipids in their solubility properties but differ in their
chemical structure.

They are synthesized from cholesterol or from other

intermediate products formed from acetate; these precursors are then
transformed into active hormones by a series of enzymatic reactions occurring within the adrenal cortex itself.

The basic structure of the adreno-

cortical hormones is the perhydrocyclopentanophenenthrene nucleus with

~o

additional angular methyl groups attached at carbon atoms 10 and 13, and
an a-ketol side chain (carbon atoms 20 and 21) attached at position 17.
The principle steroids found in the adrenal cortex include compound E
(cortisone), compound F (hydrocortisone or cortisol), 17 hydroxycorticosterone and aldosterone (see Fig. 1).

Cortisone (compound F) is the

major free circulating adrenocortical hormone in human plasma.

Cortisone

has a ketone group at C-11, a hydroxyl group at C-17 and only a minute
quantity is normally secreted each day.
groups at C-11 and C-17.

Hydrocortisone contains hydroxyl

Hydrocortisone is the predominate adrenal cor-

ticosteroid and 15 to 30 mg. are secreted per day.

Aldosterone contains

an aldehyde group attached at C-13 in place of the methyl group and
under average conditions only 150 to 300 micrograms are secreted per day.
The secretion of adrenal cortical steroids is largely controlled by
4
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Figure 1. Adrenal cortices teroids. Chemical structures of major steroids
secreted by the human adrenal cortex. (1) Perhydrocyclopentanophenenthrene
nucleus. (2) Corticosterone. Note that there are angular methyl groups at
C-18 and C-19, an ~-ketol side chain (C-20 and C-21), a ketone group at
C-3, a double bond between C-4 and C-5, an hydroxyl group at C-11; 0.5 to
2.5 mg. of this hormone secreted per day. (3) Cortisone. Ketone group at
C-11, hydroxyl group at C-17; minute quantity secreted per day. (4) Hydrocortisone. Hydroxyl groups at C-11 and C-17; 15 to 30 mg. secreted per
day. (5) Aldosterone. Aldehyde group attached at C-13 in place of the
methyl group; under average conditions, only 150 to 300 pg. secreted per day.
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adrenocorticotrophic hormone (ACTH), a straight-chain polypeptide containing 39 amino acids with a molecular weight of 4,500, synthesized and
stored in the anterior pituitary gland, and released from that organ in
response to various stimuli.
The adrenocortical hormones exist in plasma in association with a
specific binding globulin.

Presumably, only the small fraction not bound

to this protein is free to diffuse and act physiologically.

After a few

hours existence in plasma and tissue, these hormones are reduced by
hepatic enzymes to a variety of C-21 metabolites and conjugated mainly
with glucuronic acid.

Both free and conjugated corticosteroid are ex-

creted with the bile into the intestine and may then be reabsorbed by
the enterohepatic circulation.
water-soluble.

These processes render the steroids more

Elimination is primarily by the kidney.

Measurement of

these urinary metabolites is a convenient way in which to assess adrenal
function, but determinations of plasma concentration and secretory rate
are possible.
ACTH has only a fleeting existence in plasma; the exact pathways
of degradation are unknown.
Under normal circumstances, the adrenal cortical steroids are
thought to contribute to the preservation of homeostasis by regulating
(but not

initiatin~

electrolyte.

the metabolism of carbohydrate, protein, fat, and

The regulation of biochemical processes by the cortical

hormones is undoubtedly accomplished through the inhibition or stimulation of specific enzyme systems.

It cannot be stated at this time which
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enzymes are primary targets, but the most important measurable effects
of hormone action are acceleration of the conversion of glycogenic amino
acids to glycogen in the liver (gluconeogenesis), the inhibition of the
rate of peripheral utilization of glucose, the conservation of body sodium, the regulation of the rates of protein anabolism and catabolism,
and a regulatory influence upon fat mobilization and its site of deposition.

The chief hormones which influence carbohydrate, fat, and protein

metabolism are hydrocortisone and corticosterone both are known as glucocorticoids.

The adrenocortical hormone which is chiefly responsible for

the maintenance of sodium and other electrolyte balance in man is aldosterone, a so-called mineralocorticoid.

Aldosterone is unique among the

biologically important adrenal steroids in that its secretion is affected
only slightly by ACTH, but greatly by such stimuli as blood volume, sodium intake and the level of serum potassium.

The glucocort1coids have

some permissive influence upon electrolyte metabolism under physiologic
circumstances, but the mineralocorticoids, natural and synthetic, have
insignificant glucocorticoid activity.
When glucocortocoids are circulating in excessive quantities,
hyperglycemia or frank diabetes, increased protein catabolism, muscle
wasting, osteoporosis, loss of integrity of skin and blood vasculature,
increase in serum sodium, renal loss of potassium, edema, hypertension,
redistribution of fat to the face and trunk, psychic disturbances, decreased threshold to seizures, acne, polycythemia, eosinopenia, granulocytosis, lymphopenia, increased susceptibility to infection, delayed

8

wound healing, activation of peptic ulceration, and hirsutism may result.
All these undesirable effects are regularly reproduced by the administration of high doses of glucocorticoid, although individual sensitivity
plays an ·important role in determining the rapidity and degree to which
they develop.
Cortisol is biologically transported by the protein transcortin
(Burton and Jeyes, 1968).

The principle reactions in the metabolism of

cortisol are oxidation and reduction changes.

Conversion of cortisol to

cortisone is readily accomplished by a reversible reaction catalyzed by
the enzyme llB-hydroxydehydrogenase.

This biotransformation can occur

in the liver and in the lymphocytes.
Several inactive metabolites of cortisone and cortisol with no known
biological activity are known to exist.

Some of these conversions include

formation of tetrahydrocortisol in the liver, substance E of Reichstein,
substance U of Reichstein, dehydrocortisol, pregnane-liB, 17-dione, and
4-androstene-llB-ol-3.

These biotransformations are the results of com-

binations of oxidations, ·reductions, and saturation of the double bonds
of hydroxyls, ketones, and double bonds characteristic of cortisol,

These

metabolites can then be made water-soluble through conjugation mainly in
the liver, and secondarily in the kidney.

Conjugation with glucuronic

acid forms glucuronides while conjugation with sulfate produces sulfate
esters.

Both water-soluble conjugates can then be excreted through the

kidney.

The unconjugated metabolites will remain in the blood serum.

B.

Cleft Palate Induction in Animals.

9

In recent years the role

o~

congenital malformation. as one of the

leading causes of infant mortality and morbidity has been recognized.
Whenever a medi·cal p·robletn· exists, it is of value ·tO be able to reprodu.ce
the pathologic phenomena in animal experiments.

Congenital malformations

have been produced in lower classes of animals for nearly a century but
because mammals have so completely different a prenatal maternal-offspring relationship suCh experiments did not satisfy those interested in
the origins of congenital malformations in children.

The first terato-

logic method practiced in mammals, which dates back to the first decade
of this century, was the administration of x-rays to the pregnant mother
(Kalter, 1957).
Approximately four decades ago much interest in congenital malformation was aroused when it was shown that these malformations could be
induced by dietary deficiencies in pregnant animals.

Specifically Hale

(1933) showed that malformations could be produced in pigs with vitamin
A deficiencies.

Since then several investigators have produced malfor-

mations in test animals utilizing a variety of agents.
Corticosteroid hormones and ACTH have been administered to pregnant
animals of several species by a large number of investigators.

Various

workers using rats, rabbits and monkeys, usually of unspecified origin,
gave different amounts of cortisone acetate, ACTH, or other corticosteroids, intramuscularly or subcutaneously, for selected periods starting at various times before and during gestation.

Resorption and/or ab-

ortion occurred almost invariably when treatments with large doses of
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hormone were begun during the middle third of pregnancy, but the occasional survivors were normal.

The effect of lengthy treatment with cor-

tisone on fetal distribution was not minimized or blocked by adrenalectomy
of the pregnant female but the influence of ACTH in reducing litter size
and fetal weight was prevented by maternal adrenalectomy.
Walker and Fraser (1957) working with mice, produced resorptions
by administering intraembryonic injections of about .25 mg. of cortisone
between 12 and 14 days after conception.

But when injection was made

into the embryonic sac, cleft palate resulted.

However, intra-amniotic

injections of cortisone vehicle also produced cleft palate.

This result

led the authors to believe that effect was due to the observed leakage
of amniotic fluid through the hole made by the hypodermic needle, whiCh
caused a reduced hydrostatic pressure in the amnion, allowing the contracting uterus to press the embryo's head onto its chest, 1odging the
tongue between the palatine processes and thus preventing their movement.
This study was repeated by Trasler et al (1956) who, on day 13 of gestation, merely inserted a hypodermic needle through the uterine wall into
the amnion, but injected nothing.

This procedure also produced cleft

palate.
Congenital malformations in offspring of cortisone-treated pregnant
animals were first reported by Baxter and Fraser (1950), who produced
cleft palate without cleft lip in mice by such treatment.

By administra-

tion of various doses of the hormone (from 0.625 to 10 mg. per day given
for 2-4 successive days beginning different times during the second third

11

R!.Pr~gnancy)

to several

~trains

and types of mice, Fraser and Fainstat

(1951) established that the frequency of cleft palate produced in the
offspring varied with the dose given, time treated, and strain used.
The highest incidences of the malformation compatible with minimum frequency of resorption were produced by 2.5 mg. cortisone acetate per day
given for 4 successive days beginning 11 days after conception.

This

schedule produced almost 100 per cent affected young in the A/Jax strain,
about 20 per cent in the C57bl/6 strain and about 80 per cent in the
DBA/I strain.
Fraser et al (1954) suggested two different mechanisms that may be
operational in causing induced clefts:

one which causes a delay in the

rotation of the palatal shelves before palatal closure, and one which
causes a breakdown in previously fused palatal tissues.
In 1954, Walker's theory was that a delay in the average time and
rate at which shelf movement occurred was the primary cause of induced
clefts.

He cited as evidence the fact that he observed many embryos in

which one palatal shelf had horizontalized while the other remained vertical.

This finding was not often encountered in untreated embryos

according to Walker.

He also found that there was no significant dif-

ference in the size of the palatal shelves in treated and untreated animals prior to the time of palatal closure.

He did feel that fusion of

the shelves is necessary to promote growth of the shelves beyond the size
prior to closure.
Walker further suggested in 1954 that there would be a decrease in
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the force available to cause shelf movement if cortisone acted upon the
shelves directly.

Such decrease in available force might be due to:

1.

Inhibition of fiber formation.

2.

Inhibition of acid mucopolysaccharide synthesis.

3.

Change in the pattern of tissue arrangement, i.e., fiber

mucopolysaccharides.
Larsson (1961-1962) upheld the idea of Walker and Fraser (1956)
that shelves in cleft animals are retarded in horizontalization and that
the formation of substances necessary to produce the force for horizontalization is inhibited by cortisone, i.e., acid mucopolysaccharides.
He demonstrated that cortisone injection lowers the amount of sulfate
incorporated into the mouse embryo acid mucopolysaccharides.
Kalter (1957) enumerated some of the factors which determine the
frequency of appearance of animals with clefts in a cortisone-treated
litter.

Among these were:

gestation time, maternal genotype, dose of

cortisone, strain of mouse, fetal genotype, maternal weight, and fetal
weight.

Kalter also showed that there were fewer complete fetal resorp-

tions in untreated litters than in cortisone-treated litters.

Treated

litters had 30% fewer animals, and the individual cleft palate newborn
weighed less than his normal counterpart.

A lower-frequency of clefts

was noted where there were heavier mothers or more advanced parities.
Kalter (1954) made a study of the inheritance of susceptibility to
the teratogenic action of cortisone, first, by treating A/Jax and C57bl
females that were crossed to males of the other strain.

In this way Fl
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hybrid fetuses of identical genetic composition (aside from the sex chromosomes) carried by both types of pure strain females were subjected to
the influence of cortisone.

The frequency of cleft palate in suCh hy-

brids of identical genetic constitution was different when they were
carried by A/Jax females than if carried by C57bl females.

Hybrids from

A/Jax females had an incidence of 43.5 per cent cleft palate and those
from C57bl females had 3.7 per cent, indicating a potent maternal influence operating on the teratogenic efficacy of cortisone.

Fl females

of reciprocal crosses between the A/Jax and C57bl strains were then backcrossed to A/Jax males and treated.

The frequencies of malformed young

from both types of Fl mothers were about the same (25%) , eliminating the
possibility that the maternal influence mentioned above was due to a cytoplasmic factor.

Further analysis showed that the genetic composition of

both mother and fetus influenced the cortisone effect.
In an investigation of the food consumption of pregnant cortisone
treated mice, Kalter (1955) , showed that the hormone caused a significant
increase in food eaten by pregnant mice and proved that the teratogenic
effect was not a consequence of decreased food intake.
Fainstat (1954) has proved that cortisone is teratogenic in at
least one species other than mice.

In this study, rabbits of commercial

origin were given 25 or 30 mg. of cortisone intramuscularly per day for
4 successive days beginning the 14th or 15th day of gestation; of 35
offspring, 17 had cleft palate.
Several other steroid hormones have been administered to pregnant
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mice by Fraser and colleagues.

Hydrocortisone was found to be a potent

cleft palate-inducing agent (Kalter and Fraser, 1952).
firmed by Ingals and Curley (1957) •

This was con-

ACTH also produced cleft palate.

Strain A females were given 5 mg. ACTH every 6 hours for 2 or 3 days
beginning the 13th day of gestation, and cleft palate was induced in some
of the young.

Injections of 11-desoxycorticosterone were without effect

on embryonic development in mice by Burdick, Baird and Rogers (1954) and
this substance produced "some embryonic malformations ••••• in embryos recovered at term from treated ovariectomized pregnant hamsters (Tedford,

Various studies were undertaken and analyses made to further evaluate some of the residual sources of variability of susceptibility to-the
cleft palate-inducing property of cortisone.

It was first found that a

decrease in frequency of cleft palate occurred in the offspring of successive litters of treated pregnant mice (Kalter and Fraser, 1953).

By

treating primiparous mice, the weights and ages of which varied widely
it was found in members of litters of uniform parity that the cleft palate frequency was significantly inversely associated with maternal
weight, but not with maternal age (Jost, 1951).

In these three studies

mice of three different genetic constitutions were used and the average
frequencies of cleft palate were all different from one amother, but the
regression coefficients of maternal weight on cleft palate frequently were
approximately the same in all the studies, indicating that the level of
protection afforded by increased maternal weight against cortisone-
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induced cleft palate may be a constant.

Finally, it was found (Kalter,

1957), that affected offspring were significantly ligher than were their
siblings with normal palates from cortisone-treated mothers.

A decrease

in weight of young with cleft palate was also noted in the offspring of
cortisone-treated rabbits (Fainstat, 1954).

An embryological study was

made of palate closure in control and cortisone-treated mice of three inbred strains (Walker and Fraser, 1957).

These studies revealed that in

control animals the palate closed on the average at an earlier developmental age in C57bl fetuses than in A/Jax fetuses, with DBA mice being
intermediate and claimed that the strain difference between resistant
C57bl and susceptible A/Jax mice in response to cortisone was due to the
earlier closing of the palate in the C57bl strain.

Clark (1956) in his-

tological studies of the embryonic palate observed stainable elements
that increase in concentration with advancing stages of palate closure."
Control A/Jax fetuses had lower concentrations of these elements than
control C57bl's, and both types of treated fetuses showed less stainable
material than controls, with the concentration in treated A's less than
in treated C57bl' s.

Since relatively few C57bl and many A/Jax young show

cleft palate after cortisone, Clark proposed that the stainable material
was elastin and may be the physical basis for palatal shelf movement,
this being normally present in A/Jax mice nearer a critical level, and
hence less easily brought below the threshold in the resistant than in
the susceptible strain.
In rats, cortisone has repeatedly been found not to be teratogenic,
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but a potentiating effect of cortisone on the teratogenic action of
hypervitaminosis A was recently reported (Woollam and Millen, 1957).
Loevy (1962) did not feel that the tongue played an active role in
cleft formation, nor was it a major consideration in horizontalization.

I

II

She further felt that the role of the connective tissue in cleft development has been overemphasized.

She based her findings upon an investi-

gation in whiCh she injected 1.25 mg. of cortisone daily from the eleventh
to the fourteenth day in Strain A mice and achieved 100% cleft formation.
Loevy attributed cleft formation to a basement membrane which cannot be
I

penetrated by connective tissue when the shelves are continuous and ready

I'

I

to fuse.
It has not yet been determined exactly how cortisone acts to induce
the formation of cleft palate.

It is possible that there is an inter-

mediate action elsewhere in the fetus or mother, or it may act directly
on the palatine shelves.
Cortisone is not found in adrenal venous blood or peripheral blood.
Its function seems to be directed as a precursor for hydrocortisone
which is found in the peripheral circulation.

Cortisol exhibits an anti-

inflammatory action probably due to its ability to suppress the cell's
activity in producing the chemical agents responsible for inflammation.
_It is also known to elicit a mild hyperglycemia and in improvement in
overall capillary tone, resulting in diminished exudation of plasma into
the tissues.

Cortisone also causes a decrease in circulating eosino-

phils, a decrease in lymphocytes and an increase in the total white cell

:!1
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count due to an increased number of polymorphonuclear leukocytes (Krantz
and Carr, 1961).
Cortisone aids in the regulation of fat, protein, and carbohydrate
metabolism.

It is also responsible for polycythemia (an increase in the

number of red blood cells) and for a decrease in lymphoid tissue mass.
Cortisone can produce a lymphocytopenia according to Goodman and Gilman
(1965).
Dougherty et al (1961) stated that cortisol in tissue culture causes
a "pulling in" of the processes of the fibroblasts resulting in an epithelioid-appearing cell which develops numerous vacuoles filled with reducing substances.

Pinocytosis is completely absent, and the epithelioid

cells persist intact in spite of enormous damage to neighboring fibroblasts even when the tissue is extensively infiltrated by polymorphonuclear leukocytes.

The epithelioid fibroblasts have been cinemicrogra-

phically shown to be quite inactive in their movement.
Dougherty stated that the anti-inflammatory action of corticosteroids is a focal one and does not depend upon metabolites created by distant sites.

He also felt that the influences which cortisol exerts on

connective tissue are primarily due to modofications in fibroblast function.

The fibroblast is the cell responsible for the majority of struc-

tures present in connective tissue, i.e., ground substance matrix and
fibers.
Although the biologically active form of the steroid is cortisol,
Dougherty feels that cortisone is reversibly transformed to cortisol and
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hence acts as a potential reserve for cortisol when it is needed.
It was found (Bollough 1952, Sayeed 1962) that cortisone can suppress mitosis although it is unlikely that this is one of cortisone's
fundamental actions.

Roberts (1952) and Mott (1968) concluded that

maternal cortisone injections affected the palatine shelves of A/Jax
mice by suppression of mitosis, thereby causing a deficiency in the
number of cells with a subsequent decrease in the amount of intercellular substance.
Layton (1951) stated that high doses of cortisone inhibit the
synthesis of chondroitin sulfate in connective tissue.

Cavallero and

Braccine (1951) found that metachromatically stainable material had practically disappeared from the interfibrillar ground substance while Lattes
et al (1953) also stated that there is a reduction in the metachromasia
normally seen suggesting that the mucopolysaccharides of cortisonetreated tissue do not undergo the same chemical changes as in untreated
specimens.
Larsson (1962) also felt that cortisone interferes with the synthesis of the usual sulfated mucopolysaccharide content of connective
tissue, and Jacobs (1966) concluded that there is more water present in
the palates of cortisone-treated embryos and that this edema is most
striking during the critical period of palate closure.

Jacobs attributed

this edema to a decreased level of sulfated mucopolysaccharides in the
shelf mesenchyme.
In 1953, Paff and Stewart noted a reduction on the number of mast
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cells with cortisone treatment, while Birko (1953) found that it inhibits both hyaluronidase and streptococci.
In skin wounds, Ragan et al (1949) found the development of granulation tissue was markedly delayed by cortisone.

Kivirikko (1963) stated

that cortisone caused an increase of hydroxyproline and a decrease in the
amount of alkali-soluble and neutral-salt soluble collagen in the chicken
and attributed to cortisone the ability to alter collagen metabolism.
Fraser et al (1967) determined that the administration of cortisone
to a pregnant female mouse caused a reduction in the volume of the amniotic fluid (oligohydramnios) of the mouse embryo at the time of palatal
closure, but the amount of the decrease was shown to be exactly the same
in normal embryos as in embryos with clefts.

He therefore concluded that

the amniotic fluid reduction cannot be the factor that determined whiCh
co-investigators thought originally that the reduced volume of amniotic
fluid might cause a constriction of the embryo with subsequent flexion
of the neck pressing the lower jaw against the chest, thus jamming the
tongue between the palatal shelves and preventing their closure.
Kerppala and Pitkanen (1960) learned that cortisone inhibits the
uptake of oxygen by rat liver mitoChondria, reduces the activity of the
enzyme cytochrome oxidase, and uncouples the process of oxidative phosphorylation which occurs in the mitochondria.
DeVenuto et al (1968) by the use of cell fractionation and steroids
which were labeled with radioactive tritium and Carbon-14, showed that
corticosterone and cortisone exhibit a definite interaction with the
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nuclear and mitochondrial fractions of rat liver cells.
Nasjleti et al (1967) administered a single intramuscular 10 mg •

•

injec·tion of tritium-labeled cortisone to pregnant female A/Jax mice at
12~

days of gestation.

Blood samples were withdrawn from the animals at

various time intervals while they were still alive and these were analyzed by liquid scintillation as were various maternal tissues after the
animals were sacrificed.

Autoradiograms and routine hematoxylin and

eosin slides were prepared from the embryos and placentas which were obtained by Caesarean section.

The investigators found that the maternal

plasm radioactivity reached a peak 40 minutes after the injection of the
tritiated cortisone and that radioactivity could be found in the adrenal
gland, liver, kidney, spleen, and thymus as well.

Autoradiographic

examination of the placentas and embryos revealed that labeling was present on the maternal side of the placenta and in the blood channels of
the embryonic liver and heart
stered.
p~late

5~

hours after the injection was admini-

Nasjleti (1969) was not able to find labeling in the embryonic
or maxillary tissue.

Levine, Yaffe and Black (1968) compared the fetal uptake of radioactive cortisol in A/Jax (cleft palate susceptible) and C57 Black Mice
(cleft palate nonsusceptible).

Subcutaneous injections were made on day

11 of gestation with 2.5 mg. of cold carrier.

The mice were sacrificed

at intervals of 30, 60, 120, and 240 minutes.
Levine et al reported a similar rate of uptake of radioactivity in
both strains but a significantly higher amount in the A/Jax fet.uses.

He
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was able to show that the two strains had similar disappearance rates of
the labeled cortisol and the concluded difference in susceptibility between the two strains was not due to variation in placental transport but
due to differences in metabolism and/or binding by the fetuses.
Beitins, Kowarski, Shermeta, Delemos, and Migeon (1970) infused
three pregnant ewes with C-cortisol while simultaneously infusing their
fetuses with 1ff-cortisol in utero.

The fetuses were infused by catheters

through the common carotid artery, and a catheter was placed into the
external jugular vein for withdrawing blood samples.

The ewes had cath-

eters for infusion placed in the external jugular vein while blood samples
were drawn from the opposite jugular vein by venipunctures.

After surgi-

cal placement of these catheters and the animal recovery, the double constant infusion of the radioactive cortisol began.

Blood samples (mater-

nal and fetal) were withdrawn every 15 minutes for three hours.

The up-

take of the fetal cortisol in the maternal blood was measured and corrected relative to the blood flow.
fetal blood samples was made.

A similar treatment of data from the

Beitins et al reported a net transfer rate

of the hormones across the placenta in both directions but of different
magnitudes.

There appeared to be a significant barrier for the movement

of maternal cortisol to the fetus, thus allowing the fetus to maintain
lower concentrations of cortisol for independent homeostatic regulation.
Marks (1969) reported a significant amount of label on autoradiographs in the fetal palatine processes on the twelfth day of gestation
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in A/Jax mice.
tramuscularly

He injected 2.5 mg. of unlabeled cortisone acetate inthirt~

minutes prior to a second injection of tritiated

cortisol.

The animals were sacrificed five hours after the second in-

jection.

Marks reasoned that the first injection of cortisone-acetate

would overload the receptors for the metabolism of cortisone which would
allow the tritiated cortisol to circulate freely and therefore increase
its chances in finding its way to the fetus.

Dodds (1971) found that

this "loading dose" had just the opposite effect.
Marks, Schmitz (1970) also reported a significantly higher grain
count in the palatal processes in fetuses taken from the left uterine
horn than those from the right.

Schmitz also reported a significant

variation between placental and fetal tissues obtained from different.
mothers, explaining this variation by differences in maternal vascularity.
Dodds (1971) compared the uptake of tritiated cortisol when injected in A/Jax mice on the 12th day of gestation with a 2.5 mg. cortisone
acetate "loading dose" and without a "loading dose".

Dodds reported no

significant variation in the different maternal tissues (except higher
in the liver) and no variation in the various fetal tissues.

nal tissues were significantly higher than the fetal tissues.

The materHe also

found that the loading dose hinders rather than improves the uptake of
label.

A comparison of placentas from the right and left sides were

reported to have no significant difference in labeling.
Waddell (1971), using wholebody autoradiograms, studied the distribution of 14 c-cortisone in pregnant A/Jax mice.

He found little
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variation in the autoradiograms between the different stages of gestation.

He reported the highest concentration of radioactivity in the

maternal bile, liver, intestinal contents, and the kidney.

At all time

intervals, the concentrations of radioactivity in the fetuses were lower
than the pregnant female.

The fetal tissues reportedly showed a rather

even distribution with no greater amounts in the palatal buds.

He did

show accumulation of radioactivity surrounding the embryo in all gestation periods past twelve days.

With thin-layer chromatography of the

uterine fluid superimposed on x-ray film, he concluded that the yolk sac
is the cause of the difference either from a metabolic or an absorptive
standpoint.
In a comparative study between A/Jax mice and C57bl mice (Reminga
and Avery, 1972) the differential binding of l4c-cortisone was examined.
On

day 12.5 of gestation, each pregnant mouse was administered 2.5 mg.

of cortisone acetate intraperitoneally plus 5uCi of l4c-cortisone.

Thirty

minutes after the injection, the maternal liver, fetuses, and placentas
were removed for the study.
Spain (1973) using twenty-one pregnant A/Jax mice injected a solution of 50 uCi of
of gestation.

3
H-cortisol and 10 mg. of cortisone acetate on day 12

Four animals were sacrificed at each of the following

time intervals after injections:

0.5 hour, 1.0 hour, 1.5 hour, 2.0 hours,

3.0 hours and one animal at 6.0 hours.

The maternal liver, adrenal,

brain, placenta, yolk sac and the fetuses in three segments, torso, jaws,
and the remainder of the head were removed for analysis.

Each tissue was

CHAPTER III
METHODS AND MATERIALS

A.

Mice.
Segregated quantities of two strains of mice were obtained from

Jackson Laboratory in Bar Harbor, Maine.

A total of 60 female strain

C57bl and 10 female strain A/Jax were used in this study.

I

These mice

were obtained at the age of 12-15 weeks and used for approximately 7
months.

I

mating.

'

B.

Comparably aged males of the same strains were provided for

Feeding and Environment.
An environmental control room in the animal care facility was

where constant temperature and humidity was maintained.

used~

A day/night

cycle was maintained by a clock mechanism whiCh automatically turned the
lights on at 6:00 a.m. and off at 6:00 p.m.

Standard Purina Rat Chow

and tap water were given ad libitum.
C.

Mating.
Prior to mating of the mice, all females were placed in separate

cages for conditioning to the environment, for one month.
this period, mating commenced.
single female at 6:00 p.m.

At the end of

One male was placed in a cage with a

The female was then checked for the presence

of a vaginal plug at 8:00 a.m. on the following morning.

At this time

the males were removed from the cage of the female and segregated until
6:00 p.m. when they would again be placed with the female for mating.
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When a vaginal plug was found, the mouse was weighed and that day recorded
as day zero.

Since ovulation usually takes place shortly after midnight

(Grunebery, 1952) and copulation any time afterwards, an unavoidable error
of up to 8 hours must be realized.
a.m. on day 10.

The mouse was again weighed at 8:00

If a weight gain of two grams or more was measured , the

mouse was considered pregnant and placed in one of seven groups which will
be described.
D.

Group Assignment.
Pregnant mice were assigned at random to each of the seven experi-

mental groups.

Group A consisted of two C57bl mice which were weighed

and given a 10 mg. injection of normal saline on the 12th day of gestation.

This control group of pregnant mice was used to compare the effect

of cortisone on fetal and maternal weights.
Group B consisted of ten C57bl mice which were weighed and given
2.5 mg. of cortisone at 12:00 noon for a four day period commencing on
day ten.

l
~

II

Group C through F consisted of ten C57bl each which received a
single 10 mg. injection of cortisone on days 10, 11, 12 or 13 of gestation respectively.
Group G consisted of ten A/Jax mice whiCh were given a single dose
of 10 mg. of cortisone on the 12th day of gestation.
E.

Disection and Inspection.
On the 18th day postconception, the animals were weighed and sacri-

ficed by a sharp blow to the occiput followed by immediate decapitation.
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The fetuses were delivered through Caesarean section and the number and
position of the fetuses were noted.

They were then weighed and the

viable, non-viable and resorbed fetuses were recorded.

A gross micro-

scopic dissection was then performed on all fetuses and all abnormalities
were recorded.

The palate was more closely examined and classified as

normal or cleft.
The data on the frequency of cleft palate, cleft lip and palate,
viable, non-viable fetuses and resorptions were analyzed by chi square
tests.

Fetal and maternal weights were analyzed by the T-test.

In cal-

culating the frequency of cleft palate fetuses the cleft lips were omitted as this latter abnormality occurs spontaneously in both strains of
mice used.
F.

Drugs and Route of Administration.
The drug used in this study was an aqueous solution of cortisone

acetate manufactured by Upjohn and supplied in a multidose vial containing 25 mg./cc.

A total of 0.4 cc. or 10 mg. was aspirated into a 1 cc.

tuberculin syringe and administered to each test animal in Groups C
through G.

One half of the solution was injected intramuscularly into

the hamstring muscle of each leg being careful to aspirate first and
inject slowly.

Group B received 0.1 cc. (2.5 mg.) total per day for four

consecutive days.

Group A was the control group and received on day 12

of gestation a 0.4 cc. (10 mg.) injection of sterile normal saline instead of cortisone acetate.

UTERUS

I

I

I
I

Right Horn

Left Horn
Fetal Resorption

Fetal Positions in Uterine Cervix

FIGURE 3

Cll.APTER IV

FINDINGS
Table 1 shows the test results of 66 mice injected with Cortisone
Acetate, arranged by day of gestation and dose of the hormone.

Figure

2 represents the graphical distribution of normal and cleft palates
among the 425 fetuses.
Group G, consisting of A/Jax mice, shows the highest number of
clefts.
In the C57bl mice, Group B, (2.5 mg./4 days) was obviously more
affected by the cortisone than were Groups A (control receiving 0.4 cc.
normal saline) , C (receiving 10 mg. on the lOth day of gestation) , D
(receiving 10 mg. on the 11th day of gestation) , E (receiving 10 mg. on
the 12th day of gestation), F (receiving 10 mg. on the 13th day of gestation).

This was shown by the unusually high percentage of cleft pal-

ates produced in this resistent strain of mouse and also by the high
number of resorptions and non-viable fetuses.

Group C (10 day) and

Group D (11 day) responded with 17 and 21% cleft production respectively
to the effects of the drug although Group C exhibited a high percentage
of resorptions.
Other malformations observed were cleft lip associated with cleft
palate.

Four instances of this combination was observed, one of these

was seen in a fetus whose mother was in Group B (2.5 mg./day) and received
four injections over· a four day period commencing on day 10 of pregnancy.
28.
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This was a unilateral cleft palate and cleft lip.

Three instances were

observed in the A/Jax group (G) that was given a single dose of 10 mg.
of cortisone.

Two of these fetuses had unilateral cleft lip associated

with a midline cleft palate and the other fetus demonstrated a bilateral
cleft lip associated with a unilateral cleft palate.
One monster was observed in the day 13 group (Group E).

This

fetus showed fusion of the lips and lacked one eye and pinnae.
No attempt was made to find additional congenital malformations
other than

~sing

gross microscopic inspection of the external fetus.

It

is pertinent to point out that cortisone injections during pregnancy of
C57bl resulted sometimes in maternal death a few days afterwards.

More

often, however, it produced early and late embryonic deaths within litters
and of entire litters.
Maternal weights were recorded on the morning that the vaginal
plug was observed and again at the time of drug administration once pregnancy had been established.
prior to sacrificing.

A final maternal weight was recorded just

Final weights of all mothers were compared utili-

zing the T test to see if any significant differences could be shown between weights of control animals, maternal weights of treated litters
with no cleft offspring and maternal weights of treated animals producing
fetuses exhibiting cleft palates.
be nonsignificant

Weight differences were determined to

(P<.os).

Fetal weights were also recorded as were uterine positions of defective offsprings and evaluated for statistical significance.

It was
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found that the weights of fetuses obtained from animals in the control
group (A) were significantly higher than weights of fetuses obtained
from non-cleft animals (t = 10.76, P( .001) and also significantly higher
than the weights of fetuses obtained from mothers which showed cleft
fetuses (t = 11.79, P( .001).

No difference, however, could be shown

between weights of fetuses obtained from treated animals showing clefts
and treated animals producing cleft free litters.

Uterine position was

evaluated with respect to location of cleft or resorbed fetuses in order
to determine if either the distal or proximal position was more susceptible to cleft frequency or that left uterine horn or the right was more
vulnerable.

Figure 3 illustrates how uterine positions were labeled.

The various possible positions were statistically evaluated by chi square
and found to be insignificant.

Uterine position could not be correlated

with either cleft formation or frequency of resorption.
Finally in order to determine if any statistical difference could
be shown between the multi-injection technique and the single injection
teChnique, the data was summarized and evaluated as to cleft versus noncleft and viable versus non-viable and subjected to chi square analysis.
The data is shown i~ Table 1.

The results show that if the 10 mg. single

injection technique is used on day 10 or 11 of pregnancy in the C57bl
.strain of mouse that there is no significant difference when compared to
the 2.5 mg./day multi-injection teChnique.
Mice which were administered cortisone on day twelve (Group E)
were considerably different both in fewer clefts (chi square= 7.3) and
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fewer resorptions (chi square = 11.4, P ( .001) when compared to the 2. 5
mg./day group.

Resultant litters from Group F (day 13 injection) exhi-

bited even greater differences with a chi square= 17.5 for clefts and
a chi square = 20.4 for resorptions, (P< • 001) when compared to the same
group B, 2.5 mg./day.

1:
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CHAPTER V

DISCUSSION

A ten milligram injection of cortisone acetate had considerable
tetratogenic effect on the developing embryo of the C57bl pregnant
mouse.

The effect of the drug administration was most profound when

given approximately 48 hours before palate closure as previously noted
by Chaudhry (1967).

When a ten milligram dose was given on day eleven

of gestation, the results consistently produced around 20% cleft palate
in this previoUsly defined resistent strain (Walker, 1957).

The findings

corroborate those of Fraser and his colleagues, who injected inbred
strains of mice with daily doses of cortisone for a period of four days
and demonstrated its capacity for inducing cleft palates in the young.
Our experiments show that this four day regimen can be narrowed to a
single day with a single dose and further that the response is dependent
upon the timing and dose of cortisone given.

There is no question that

genetically determined susceptibility also influences expression of the
acquired defect; but genetic susceptibility is shown to be one of multiple factors that contribute to the genesis of cleft palate in unborn
mice.

The data shown in Table 1 narrow markedly the apparent discrepancy

in timing between the cortisone induced disturbances.

Palates of embryos

in the C57bl strain of mice normally close about the 14th or 15th day as
opposed to the 16th day for the A/Jax strain (Kalter, 1952).

Thus it

would be expected that this earlier maturing mouse would behave as it has
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been shown and exhibit the teratogenic effects one to two days and
earlier than its highly susceptible counterpart, the A/Jax mouse.

This

so called incubation period of 48 hours immediately preceeds the critical period of accelerated differentiation and fusion when the embryo
appears to be in a highly susceptible state and ready to depart from
normal ontogenetic sequences of morphogenesis.
From the observed incidence of cleft palate, it is quite obvious

l

l

that cortisone in a 10 mg. dose is equally as effective as a teratogenic
agent when administered on day 10 or 11 of gestation.

However this

effect declines sharply when the drug is given on the 12th or 13th day
of pregnancy.

This study indicates a trend toward a higher percentage

of clefts in groups subjected to the four day regimen of injections
(2.5 mg./day) although no statistical difference could be shown between
drug administration regimes.

While animals were randomly selected for

I,
II

the other groups, apparently significantly younger and lighter mothers
were used for multi-injection group B.

This could probably account for

the relatively higher percentage of clefts and resorptions in this group
(Kalter, 1955).
The data further suggest that there is a significant reduction in
fetal weights of animals borne by cortisone treated mothers.

It was

shown that not only are cleft fetuses significantly lighter than control
but also non cleft fetuses of cortisone treated mothers are significantly
lighter than the normal palated fetuses in the control group.

From this

fact we suggest that the cleft manifestation may partly stem from a more

I
,I
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general stress imposed on the maternal environment and not solely by
direct action of cortisone against the affected fetus.
From the foregoing it can be seen that congenital malformations
are but one manifestation of pathology inflicted by cortisone injections.
Such experimental methods are capable of inducing more severe disturbances
such as abortion, fetal resorption, or neonatal death.

But while it is

relatively easy to interrupt pregnancy by environmental interferance, it
is more difficult to obtain young with congenital malformations, since
this requires an experimental arrangement that permits damaging the
embryo without killing it.

To achieve such balance, the teratogen, its

dose, and timing, must be coordinated.

CH.APTER VI .
SUMMARY AND CONCLUSIONS

Cortisone acetate was administered as a teratogenic agent to 5
groups of C57bl mice and one group of the A/Jax strain of mice.
additional C57bl group served as a control.

An

Each test group was injected

on a single day of pregnancy except for one group which received a four
day regimen of injections, equal in amount to that given the other groups
on a single injection.

These injections were given on the lOth, 11th,

12th and 13th day of gestation for the purpose of determining on which
day the agent was most effective in producing cleft palate.
1.

The eleventh day of pregnancy proved to be the most feasible

from the standpoint of percentage of clefts produced, per viable fetuses
and number of resorptions suffered.
2.

It was determined that fetal weights of treated animals were

significantly lighter than weights of control litters.
3.

Maternal weights were determined to be unrelated to cleft

formation.
1:

j!

4.

It was shown that in the C57bl strain, a single injection drug

administration can adequately replace a multi-injection technique spread
over a 4 day period if the single injection is done on the eleventh day.
5.

Occurrances of malformation are unrelated to uterine position

of the fetus.
The induced defect was always in the midline and not associated
35
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with the cleft lip.

The four observed occurrances of cleft palate with

cleft lip was 1%, a finding in agreement with other investigators
(Hackman and Brown, 1972).

This defect resembled the inherited cleft

which to the author's knowledge has never been produced to date by
known teratological methods.

~

TABLE 1 •. Results of Cortisone Acetate Injection in 66 Pregnant Mice
Number Resorptions
and Non-Viable
Fetuses *

Number of
Clefts **

Percentage of
Viable Fetuses
with Cleft
Palate

Grou£_

Injection
Day(s) of
Gestation

Number of
Litters
Examined

Dose
Administered

A

Control
(12 day)

10

0.4 cc.
Sterile Saline

55

4

0

0

B

10, 11
12, 13

10

10 mg.
(2. 5 mg. /day)
(0.1 cc.)

59

27

14

44%

lOth day

10

10 mg.
(0.4 cc.)

65

36

5

17%

11th day

10

10 mg.
(0.4 cc.)

57

10

10

21%

10

10 mg •.
(0.4 cc.)

59

10

8

16%

77

12

7

11%

. 53

15

36

98%

c
D
E

12th day

F

13th day

10

10 mg.
(0. 4 cc.)

G

A/Jax
12th day

6

10 mg.
(0. 4 cc.)

Number of
Fetuses

* Significant chi square comparisons between groups for non-viable fetuses (P 0.05)
A vs. B, A vs. C, A vs. G, B vs. D, B vs. E, B vs. F, C vs. D, C vs. E, C vs. F, C vs. G.

** Significant chi square comparisons between groups for clefts (P

.OS)

A vs. B, A vs. C, A vs. D, A vs. E, A vs. F, A vs. G, B vs. E, B vs. F, B vs. G, C vs. G, D vs. G, E vs. G, F vs. G.
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